Annual Working Capital
$235.80 M
+$596.09 M+165.45%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual working capital is $235.80 million, with the most recent change of +$596.09 million (+165.45%) on December 31, 2023.
- During the last 3 years, IBRX annual working capital has risen by +$192.22 million (+441.09%).
- IBRX annual working capital is now at all-time high.
Performance
IBRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$102.19 M
-$78.53 M-43.45%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly working capital is $102.19 million, with the most recent change of -$78.53 million (-43.45%) on September 30, 2024.
- Over the past year, IBRX quarterly working capital has dropped by -$78.53 million (-43.45%).
- IBRX quarterly working capital is now -56.66% below its all-time high of $235.80 million, reached on December 31, 2023.
Performance
IBRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IBRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +165.4% | -43.5% |
| 3 y3 years | +441.1% | +118.7% |
| 5 y5 years | - | +118.7% |
IBRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.4% | -56.7% | +118.7% |
| 5 y | 5-year | at high | +165.4% | -56.7% | +118.7% |
| alltime | all time | at high | +165.4% | -56.7% | +118.7% |
ImmunityBio Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $102.19 M(-43.5%) |
| Jun 2024 | - | $180.72 M(+27.3%) |
| Mar 2024 | - | $141.96 M(-39.8%) |
| Dec 2023 | $235.80 M(-165.4%) | $235.80 M(+89.0%) |
| Sep 2023 | - | $124.76 M(-122.8%) |
| Jun 2023 | - | -$546.65 M(+21.1%) |
| Mar 2023 | - | -$451.46 M(+25.3%) |
| Dec 2022 | -$360.28 M | -$360.28 M(-598.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $72.25 M(-127.7%) |
| Jun 2022 | - | -$261.06 M(+54.8%) |
| Mar 2022 | - | -$168.67 M(+386.8%) |
| Dec 2021 | -$34.65 M(-179.5%) | -$34.65 M(-219.3%) |
| Sep 2021 | - | $29.04 M(-26.1%) |
| Jun 2021 | - | $39.30 M(+99.4%) |
| Mar 2021 | - | $19.71 M(-54.8%) |
| Dec 2020 | $43.58 M | $43.58 M |
FAQ
- What is ImmunityBio annual working capital?
- What is the all time high annual working capital for ImmunityBio?
- What is ImmunityBio annual working capital year-on-year change?
- What is ImmunityBio quarterly working capital?
- What is the all time high quarterly working capital for ImmunityBio?
- What is ImmunityBio quarterly working capital year-on-year change?
What is ImmunityBio annual working capital?
The current annual working capital of IBRX is $235.80 M
What is the all time high annual working capital for ImmunityBio?
ImmunityBio all-time high annual working capital is $235.80 M
What is ImmunityBio annual working capital year-on-year change?
Over the past year, IBRX annual working capital has changed by +$596.09 M (+165.45%)
What is ImmunityBio quarterly working capital?
The current quarterly working capital of IBRX is $102.19 M
What is the all time high quarterly working capital for ImmunityBio?
ImmunityBio all-time high quarterly working capital is $235.80 M
What is ImmunityBio quarterly working capital year-on-year change?
Over the past year, IBRX quarterly working capital has changed by -$78.53 M (-43.45%)